Clinical Outcome Following Total Hip Arthroplasty With the SMF Stem (SMF-S&E)
Clinical Outcome Following Total Hip Arthroplasty With the SMF Stem A Prospective, Consecutive Series, Multi-center Clinical Study
Sponsor: Smith & Nephew, Inc.
Terminated
The study was prematurely terminated by S+N due to business reasons. After an extensive review of all ongoing studies with the focus on which studies are still required for regulatory obligations S+N took the decision to close the SMF S\&E study.
Other terminated trials from Smith & Nephew, Inc.
- Acute Wounds · Oct 2025
- Meniscus Tear · Apr 2024
- Arthroplasty · Mar 2024
- Avascular Necrosis · Phase NA · Feb 2024
- Osteoarthritis of the Shoulder · Dec 2023
More terminations from Smith & Nephew, Inc.
This observational or N/A phase trial investigates Joint Diseases and is currently terminated or withdrawn. Smith & Nephew, Inc. leads this study, which shows 13 recorded versions since 2008 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
13 versions recorded-
Sep 2025 — Present [monthly]
Terminated
-
Sep 2024 — Sep 2025 [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
Dec 2021 — Jul 2024 [monthly]
Terminated
-
Mar 2021 — Dec 2021 [monthly]
Terminated
Status: Active Not Recruiting → Terminated
▶ Show 8 earlier versions
-
Jan 2021 — Mar 2021 [monthly]
Active Not Recruiting
-
Jan 2019 — Jan 2021 [monthly]
Active Not Recruiting
-
Nov 2018 — Jan 2019 [monthly]
Active Not Recruiting
-
Oct 2018 — Nov 2018 [monthly]
Active Not Recruiting
-
Aug 2018 — Oct 2018 [monthly]
Active Not Recruiting
-
Jun 2018 — Aug 2018 [monthly]
Active Not Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Active Not Recruiting
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Active Not Recruiting NA
First recorded
Feb 2008
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Smith & Nephew, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .